Project Grant R01AI190069
Award Date
3/21/25
Completion Date
2/28/30
Dollars Obligated
$483K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Ohio, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,264,525.00 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. The grant, which runs from June 1, 2024 to April 30, 2029, will fund research to identify genomic regions and mutations that allow a rodent hepatitis C-like virus (RN-2M) to establish chronic infection in mice. The research aims to elucidate...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $1,511,827.00 in funding to the Research Institute at Nationwide Children's Hospital to develop an animal model to study the heterogeneous outcomes of Hepatitis C Virus (HCV) infection and pathogenesis. The project aims to identify the viral and immune determinants that lead to spontaneous clearance versus chronic HCV infection using a...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $244,440 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Albert Einstein College of Medicine in Bronx, New York. This funding will support a research project titled "Role of Cytolytic ZEB2+ Memory CD4+ T Cells in Protection Against Liver Stage Malaria." The project aims to use murine models to explore the kinetics, differentiation, functions, and protective...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,157,123 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Childrens Hospital Medical Center in Cincinnati, Ohio. The grant will fund a project titled "Viral and Cellular Determinants of HIV-1 Assembly" that aims to define the host recycling pathways and cellular components essential for incorporation of the HIV envelope protein into viral particles. Key goals of the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) will support $639,084 in research to elucidate the heterogeneity and functional differences among naive CD8 T cells, which are the predecessors of antigen-experienced T cells. The 5-year project, awarded to Childrens Hospital Medical Center in Cincinnati, Ohio, aims to investigate both mouse and human naive CD8 T cell populations to understand...
This $2,225,199 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to advance understanding of the immune responses underlying hepatitis B virus (HBV) functional cure. The primary objectives are to:
Define the functions and molecular signatures of HBV-specific CD4 T cells that are important for viral suppression versus functional cure.
Characterize HBV-specific humoral...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $781,367 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Weill Medical College of Cornell University. The grant, awarded on January 25, 2024, will support research to define and maximize the impact of CD8+ T-cell selection on the landscape of HIV integration sites. The goal is to optimize strategies for eradicating the persistent reservoir of HIV-infected cells and achieve...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $444,600 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. The grant, with a period of performance from July 15, 2024 to May 31, 2026, will fund research to understand the immune responses of infants with congenital syphilis infection. The project aims to identify immune cell markers and serum...
This federal Project Grant award in the amount of $1,179,316.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award is focused on understanding the mechanisms that regulate CD8 T cell responses during chronic viral infection, with the goal of improving immunotherapies to increase T cell function and reduce viral load. Key aspects of the research include:
Determining the role of...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $2.3 million Project Grant to the University of California, Davis to fund research targeting CD4 T follicular helper cells for enhancing HIV vaccine-induced humoral immunity. The two-year award, issued on May 12, 2021 under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support preclinical studies in rhesus macaques to better understand the immunological mechanisms...